Remedium Lifecare Ltd (BSE: 539561) is a Mumbai, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹10 Cr, it ranks #5,081 by market cap among the 6,137 Indian listed companies on FinBizNet, and #84 of 86 in Medicinal Chemicals and Botanical Products. At ₹0.24 (as of 25 Oct 2026), the share price is 84.9% below its 52-week high of ₹1.59 and 4.3% above its 52-week low of ₹0.23. The share price is down 84.0% over one year and down 31.4% over three months.
| Current Price | ₹0.24 |
|---|---|
| Market Cap | ₹10 Cr |
| BSE Code | 539561 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 5 |
| Return on Equity | 4.90% |
| Return on Assets | 0.04% |
| 52-Week Range | ₹0.23 – ₹1.59 |
| 1-Year Price Change | -84.0% |
| 3-Month Price Change | -31.4% |
| Beta (1Y) | 0.97 |
| Headquarters | Mumbai, Maharashtra |
| Website | www.remlife.com |
Supha Pharmachem Limited, a pharmaceutical company, trades and sells active pharmaceutical ingredients (API) and intermediates in India and internationally. The company offers API intermediates and other products for the use in iso propyl alcohol, cyclohexane di iso propyl amine, ethyl acetate, hydrazine hydrate, iso propyl alcohol, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride and carbonate, amino isophthalic acid, tellurium(iv) oxide, grignard reagent, iodine, selenium metal powder, and trimethyl sulfoxonium iodide. It also provides tartaric acid salt, thiophenetosylate, couple amine hydrochloride, pantoprazole sulphide, chloro compound, benzimidazole, pantoprazole n-oxide, 4-chloro benzhydryl piperazine, cetirizine base, levo CBP, 2 PMS, indole II, indole III, and R- amide. The company was formerly known as Remedium Lifecare Limited and changed its name to Supha Pharmachem Limited in December 2025. Supha Pharmache
1. Trading & Manufacturing of Bicycles Parts-This segment manufactures and trades in bicycles and bicycle parts.
1. Pharmaceuticals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,21,995 Cr | 36.4 | 14.72% | ₹15,300 Cr | +5.4% |
| Zydus Lifesciences Ltd | ₹1,12,020 Cr | 22.2 | 18.32% | ₹8,017 Cr | +14.7% |
| Laurus Labs Ltd | ₹1,11,310 Cr | 125.3 | 17.74% | ₹2,026 Cr | +125.7% |
| Cipla Limited | ₹1,07,048 Cr | 27.6 | 11.74% | ₹7,119 Cr | -14.7% |
| Dr.Reddys Lab | ₹1,02,611 Cr | 24.1 | 11.52% | ₹8,698 Cr | -0.9% |
| Aurobindo Pharma Ltd. | ₹95,910 Cr | 26.8 | 9.93% | ₹9,150 Cr | +41.7% |
| Mankind Pharma | ₹93,977 Cr | 48.7 | 12.45% | ₹4,031 Cr | -9.9% |
| Lupin Ltd | ₹89,426 Cr | 16.6 | 26.91% | ₹8,277 Cr | -1.1% |
| Remedium Lifecare Ltd | ₹10 Cr | 5 | 4.90% | — | -84.0% |
Listed by market capitalisation. Ratios are shown for context only.
Remedium Lifecare Ltd is trading at ₹0.24, with a market capitalisation of ₹10 Cr.
Remedium Lifecare Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Remedium Lifecare Ltd has a P/E of 5 and a return on equity of 4.90%.
Remedium Lifecare Ltd is listed on the BSE under the scrip code 539561.
Remedium Lifecare Ltd's share price is down 84.0% over one year and down 31.4% over three months. Its 52-week range is ₹0.23 to ₹1.59.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.